Munich Re Puts Margins Ahead of Market Share as Asia Pullback Deepens

Munich Re slashes Asian underwriting 18.5% amid softening market, wows analysts with diversification strategy. Stock down 14% in month but valuation at P/E 8.9 offers upside.

Munich Re is sending a clear message to investors: profitability matters more than premium volume. The German reinsurer slashed its underwriting exposure in Asia by 18.5% during the April renewal season, walking away from business after regional prices dropped an average of 3.1%. The move, a deliberate contraction in the property and casualty segment, comes as the broader market softens and competitors chase growth.

The strategic retreat is winning cautious applause from analysts, even as earnings forecasts get trimmed. JPMorgan cut its price target on the stock from €655 to €590, citing lower profit estimates through 2028 — down as much as 5% — on expected weakness in P&C reinsurance. Yet the bank kept its “Overweight” rating, pointing to what it calls the company’s “Plan B”: diversification through life/health reinsurance and the ERGO primary insurance unit. Analyst Kamran Hossain argued this broader base can absorb swings in the core business.

The stock found some footing Monday, trading at €486.10, a gain of 2.32%. The advance offers little relief from a punishing stretch: the shares have lost 13.93% over the past 30 days and 15.90% over the past twelve months. The distance to the 50-day moving average of €530.71 remains wide, suggesting the bounce is more a stabilization attempt than a true reversal. At €467, the 52-week low set on 13 May still lurks just 4% below the current level.

First-quarter numbers painted a mixed picture. Net profit surged to €1.714 billion from €1.094 billion a year earlier, helped by low major-loss costs of just €130 million — a fraction of the €1 billion-plus hit from the Los Angeles wildfires in the prior-year period. Insurance revenue, however, slipped to €15.0 billion from €15.8 billion, which the company attributed to negative currency effects rather than operational deterioration. The annual net profit target of €6.3 billion remains unchanged.

Management is reinforcing its balance sheet and shareholder returns in parallel. The major-loss budget has been raised to 18% of earned premiums from 17%, and €90 million in provisions have been booked for potential Iran-related claims. Meanwhile, the first tranche of a €900 million share buyback programme kicked off on 14 May, supporting earnings per share even as organic growth falters. A dividend of €24.00 per share is proposed for 2025, with analysts penciling in the same for 2026.

The valuation argument is gaining traction. At a price-to-earnings ratio of roughly 8.9, Munich Re trades below the sector average of about 11.0. The analyst consensus target stands at €560, some 15% above the current market price, while JPMorgan’s revised €590 offers even more upside. The gap between the stock and its price targets has widened notably, but the bulls argue the risk-reward profile has improved.

For the chart-watchers, the €480 zone is the near-term line in the sand. Holding above it keeps the stabilisation narrative intact; a break below would put the May low back in play. Clearance of the 50-day moving average would be the next milestone for a more durable recovery — but the market is not there yet.